Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar and Radiotherapy in NSCLC Brain Metastasis
NCT03614065Phase 2Unknown
- Start
- Feb 2017
- Primary completion
- Nov 2018
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in non-small cell lung cancer (NSCLC). Status: unknown.
02
Drugs
endostar
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03614065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03614065.